Top drug distributors in talks to settle opioid litigation for $18 billion, report says

Health, Fitness & Food

State and local officials are reportedly in talks with three major drug distributors on a potential $18 billion settlement of litigation that blames them for helping to fuel the U.S. opioid epidemic.

The potential settlement, according to the Wall Street Journal, would require McKesson Corp., AmerisourceBergen Corp. and Cardinal Health to collectively pay the $18 billion over 18 years. Drugmaker Johnson & Johnson is also involved in the discussions to pay extra money, the WSJ reported, citing people familiar with the discussions. 

This is breaking news. Please check back for updates.

Products You May Like

Articles You May Like

Biologics Hold Promise as Nasal Polyp Treatment
Illiteracy may triple dementia risk
Yale study uncovers why belly fat surrounding organs increases as people age
Study: 15,000 cases of hypophosphatasia potentially undetected in Spanish population
Self-destructive mitochondria may set the stage for neurodegeneration in ALS

Leave a Reply

Your email address will not be published. Required fields are marked *